William Blair Reiterates Albireo Pharma (ALBO) at Outperform, Bylvay Can Become a Blockbuster in Several Indications
Tweet Send to a Friend
William Blair analyst Tim Lugo reiterated an Outperform rating on Albireo Pharma (NASDAQ: ALBO), following the company's recent business update.The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
